Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Malin Svensson

Malin Svensson

Biomedical analyst

Malin Svensson

Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels.

Author

  • Marju Orho-Melander
  • Mia Klannemark
  • Malin Svensson
  • Martin Ridderstråle
  • Cecilia Lindgren
  • Leif Groop

Summary, in English

The calpain-10 gene (CAPN10) has been associated with type 2 diabetes, but information on molecular and physiological mechanisms explaining this association is limited. Here we addressed this question by studying the role of CAPN10 for phenotypes associated with type 2 diabetes and free fatty acid (FFA) metabolism. Among 395 type 2 diabetic patients and 298 nondiabetic control subjects from Finland, the SNP-43 allele 1 (P = 0.011), SNP-63 allele 2 (P = 0.010), and the haplotype combination SNP-44/43/19/63 1121/1121 (P = 0.028) were associated with type 2 diabetes. The SNP-43 genotypes 11 and 12 were associated with higher fasting insulin and homeostasis model assessment (HOMA) insulin resistance index among control subjects (P = 0.021 and P = 0.0076) and with elevated FFA among both control subjects (P = 0.0040) and type 2 diabetic patients (P = 0.0025). Multiple regression analysis further indicated that SNP-43 is an independent predictor of FFA levels (P = 0.0037). Among 80 genotype discordant sibling pairs, the SNP-43 allele 1 was associated with elevated fasting serum insulin and HOMA index (P = 0.013 and P = 0.0068). None of the four SNPs showed distorted transmission of alleles to patients with type 2 diabetes in a qualitative transmission disequilibrium test, including 108 trios. Because FFA and insulin resistance are known to predict type 2 diabetes, the finding that variation in the CAPN10 gene influences FFA levels and insulin resistance may provide an explanation for how the CAPN10 gene increases susceptibility to type 2 diabetes.

Department/s

  • Genomics, Diabetes and Endocrinology
  • Diabetes - Clinical Obesity
  • Department of Clinical Sciences, Malmö

Publishing year

2002

Language

English

Pages

2658-2664

Publication/Series

Diabetes

Volume

51

Issue

8

Document type

Journal article

Publisher

American Diabetes Association Inc.

Topic

  • Endocrinology and Diabetes

Keywords

  • Middle Age
  • Support
  • Insulin Resistance : genetics
  • Insulin : blood
  • Human
  • Haplotypes
  • Genotype
  • Finland
  • Female
  • Nonesterified : blood
  • Case-Control Studies
  • Fatty Acids
  • Male
  • Non-U.S. Gov't
  • Calpain : genetics
  • Body Constitution
  • Blood Glucose : metabolism
  • Alleles

Status

Published

Research group

  • Genomics, Diabetes and Endocrinology
  • Diabetes - Clinical Obesity

ISBN/ISSN/Other

  • ISSN: 1939-327X